CL Colgate-Palmolive Company
Colgate-Palmolive Company (CL) trend channel, buy level and 3-month target on Trade The Path. Sector: Basic Materials. Listed on ARCA. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. If this ticker has no settled sample yet, treat the numbers as a geometric read, not a track record. Information only, not financial advice.
Broken down below, rising on both timeframes
Price has closed below the channel. Support has failed — treat the buy target with caution.
Read from the last 12 months of history we hold: rising, drifting +23% a year. The nearest ceiling overhead is US$94.03. What would overturn this: a close below US$89.70 — the floor of the channel being read — after which the trend, not the entry, is what was wrong.
- 12 months read from
- US$89.73 – US$94.03 Rising channel, +23% a year
- Position in that channel
- -62% below the floor of it — 0% is the floor, 100% the ceiling
Price history, with the path projected 3 months forward
- Daily close
- Upper trend line (12 months)
- Lower trend line (12 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
No published call today because price has broken 3.0% below the channel floor, which is a fall out of the trend rather than a dip within it. No alerts are sent. The buy and target below are still this site's read of the fitted channel.
Buy now
US$86.99
last close · 16 Sept 2026
Channel buy is US$89.76; last close is the better price available now.
Our target
US$92.24
by 16 Dec 2026
Projected move
6.0%
gross, before costs
Last close is our buy — the best price available now.
- Upper line touches
- 4
- Lower line touches
- 5
- Fit confidence
- 70%
- Fitted
- 16 Sept 2026
Company information
Fundamentals are not available for this instrument from the current data provider.
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.